Washington Trust Advisors’s Cardinal Health CAH Stock Holding History

Washington Trust Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-190	Closed	-$13K	–	801
2022 Q3	$13K	Buy	+190	New	+$12K	﹤0.01%	560

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Washington Trust Advisors's CAH Position: Q4 2022 in Review

Washington Trust Advisors sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 190 shares — an estimated $13K sold.

Washington Trust Advisors first reported a position in CAH in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 930 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

Washington Trust Advisors reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
Washington Trust Advisors sold 190 Cardinal Health shares in Q4 2022, an estimated $13K.
Washington Trust Advisors first reported a position in Cardinal Health in Q3 2022 and held it in 1 quarter.
Washington Trust Advisors's Cardinal Health position peaked at $13K in Q3 2022.
930 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Washington Trust Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.